Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-656P is a human pseudogene derived from the U6 small nuclear RNA family. Pseudogenes are genomic DNA sequences similar to known genes but generally non-functional due to accumulated mutations or lack of essential regulatory elements. The U6 small nuclear RNAs (snRNAs) play a critical role in pre-mRNA splicing by assembling in the spliceosome complex, but pseudogenes like RNU6-656P do not encode functional snRNA and do not participate in splicing. Some pseudogenes can have biological roles as non-coding RNAs that influence gene regulation through mechanisms such as competing for microRNAs or interacting with RNA-binding proteins, but specific functional studies for RNU6-656P are not reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 656, pseudogene (RNU6-656P).